Twinlab Consolidated Holdings Valuation
Is TLCC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TLCC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TLCC ($0.01) is trading below our estimate of fair value ($0.33)
Significantly Below Fair Value: TLCC is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TLCC?
Key metric: As TLCC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is TLCC's PS Ratio? | |
|---|---|
| PS Ratio | 0.3x |
| Sales | US$12.71m |
| Market Cap | US$1.84m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7.6x |
| Enterprise Value/EBITDA | -10794.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does TLCC's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.3x | ||
MACE Mace Security International | 0.2x | n/a | US$1.2m |
CYAN Cyanotech | 0.1x | n/a | US$2.5m |
ELAB Elevai Labs | 0.4x | n/a | US$1.1m |
KGKG NuVibe | 0.4x | n/a | US$1.0m |
TLCC Twinlab Consolidated Holdings | 0.3x | n/a | US$1.8m |
Price-To-Sales vs Peers: TLCC is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.3x).
Price to Sales Ratio vs Industry
How does TLCC's PS Ratio compare vs other companies in the US Personal Products Industry?
| 27 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| Industry Avg. | 1.0x | 4.7% | |
TLCC Twinlab Consolidated Holdings | 0.3x | n/a | US$1.84m |
HLF Herbalife | 0.2x | 1.8% | US$847.66m |
NUS Nu Skin Enterprises | 0.2x | -0.06% | US$372.34m |
| 27 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
| Industry Avg. | 1.0x | 26.0% | |
TLCC Twinlab Consolidated Holdings | 0.3x | n/a | US$1.84m |
Price-To-Sales vs Industry: TLCC is good value based on its Price-To-Sales Ratio (0.3x) compared to the US Personal Products industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is TLCC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate TLCC's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Beauty Health
US$184.9m
Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.
SKIN
US$1.39
7D
-22.3%
1Y
-37.5%
Kimberly-Clark de México S. A. B. de C. V
Mex$86.0b
Manufactures, distributes, and sells disposable products in Mexico.
KCDM.F
Mex$1.37
7D
-5.8%
1Y
n/a
Reynolds Consumer Products
US$5.8b
Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.
REYN
US$27.61
7D
-0.5%
1Y
6.2%